HPV

The American College of Physicians urges clinicians to make sure adult patients, especially the most vulnerable, are protected against preventable diseases as COVID spreads and flu is imminent.

How many young adults in the US actually receive their recommended doses of HPV vaccine? Take this 7-question quiz on a new report to learn more about the trends.

English- and Spanish-speaking parents cited widely differing reasons for avoiding vaccination for their eligible daughters or failing to ensure the 3 doses were received.

Most parents of boys aged 9 to 18 years do not know that an HPV vaccine is available for their sons. One major factor is a lack of information. This is where you play a vital role.

Key points for primary care physicians from a new study: HIV-positive women are vulnerable to invasive cervical cancer. This finding underscores the need for screening per guidelines and to follow-up on abnormal Pap smears.

The human papillomavirus is also easily transmitted to the anus in men who have sex with men.

Patients with ulcerative colitis and Crohn’s disease typically don’t receive preventive services at the same rate as general medical patients. Vaccination is a key area of confusion.

Diagnostic challenge: Two case reports of easily treated and innocuous causes of lesions in the outer ear. Chondrodermatitis nodularis helicis is associated with long cellphone use. Verruca vulgaris is caused, like all other warts, by human papillomavirus.

Patients with IBD may have discomfort for 3 to 5 years before a diagnosis is made. Many are treated unsuccessfully with antibiotics, anti-spasmodics, or narcotics. Here, read 5 important tips, plus a bonus point, to help streamline diagnosis and management.

Physicians are being under-reimbursed for vaccinations nearly half the time, according to new data released by athenahealth. Most physicians are properly reimbursed for the cost of the vaccine itself, but getting paid for administration of the vaccine is another matter.

Minnesota Congresswoman Michelle Bachmann recently caught the attention of a lot of people when, during a television interview following a Presidential debate, she claimed that the HPV vaccine has “very significant consequences.”

For 20 years, a lesion has been slowly growing on the penis of a 51-year-old man. He has noted bleeding and a foul-smelling discharge from the mass. Recently, the patient experienced a 30-lb weight loss. He has had 5 sex partners in his lifetime but has been monogamous for the past year.

One of the most important roles for primary care practitioners is the review and implementation of necessary immunizations across a broad spectrum of age.

For several weeks, a 33-year-old man has had an asymptomatic lesion on the head of the penis. He has had a new sex partner in the past few months but is unaware of any health problems she may have. What is the likely cause of this lesion?

A 30-year-old man with a 15 packyear smoking history presented for a follow-up evaluation of an asymptomatic whitish lesion on the tongue of 4 months’ duration. The lesion had not responded to oral therapy with either nystatin or fluconazole. The patient was distressed about the lesion’s appearance and his inability to remove it with a toothbrush.

The prevalence of anal human papillomavirus (HPV) infection was 24.8% among a study population of 222 heterosexual men who confirmed that they had never engaged in male-male sexual intercourse. 1

During the past few years, several vaccines have been added to the adult immunization schedule. The human papillomavirus (HPV) vaccine is recommended for girls and women aged 11 to 26 years (minimum age, 9 years) to prevent cervical cancer, precancerous or dysplastic lesions, and genital lesions caused by HPV types 6, 11, 16, and 18.

MONTREAL -- Viral testing to detect cervical cancer appears to outperform the conventional Pap smear in some respects, researchers here have concluded.

AMSTERDAM -- Testing for the DNA of human papillomavirus -- combined with a Pap smear -- reveals the lesions that lead to cervical cancer earlier than a Pap smear alone, researchers said here.

CHICAGO -- Immunization with Gardasil, a vaccine designed to prevent infection with human papilloma virus types 6, 11, 16, and 18 may also offer women significant protection against so-called "cousins" of those viral strains, reported researchers here.

ATLANTA -- America's children are getting their shots, but adolescents are lagging, according to the CDC.

HOUSTON -- Human papillomavirus (HPV) infections are likely buoying up oropharyngeal cancer rates while other head and neck cancers decline, researchers said.

VANCOUVER, British Columbia -- Asking patients to collect their own vaginal specimens for HPV testing proved an effective initial screening method among high-risk women, researchers here found.

BRISTOL, England -- For universal vaccination of pre-adolescent girls against human papillomavirus, the development of the vaccine was only the first step to wide-scale cancer prevention.

ROCKVILLE, Md. -- The bivalent vaccine that protects against infection with human papillomavirus does not affect HPV clearance in women with pre-existing infections and should not be considered a treatment modality.

An 82-year-old man is seen for annual physical examination in the nursing home. He has resided there for 1 year because of the aggregate impact of multiple medical problems including, most prominently, laryngeal swallowing dysfunction associated with vocal cord paralysis.

SYDNEY, Australia -- A computerized system for reading liquid-based cytology slides outperformed conventional cytology for detecting cervical abnormalities, investigators here reported.

HELSINKI -- About 90% of early signs of cervical cancer in young women can be prevented by an investigational vaccine against human papillomavirus, according to interim data.

PHILADELPHIA -- The past 12 months have seen new drugs and vaccines for indications from quitting smoking to preventing HPV. Which ones should clinicians embrace and which should they be more cautious about?

HELSINKI, Finland -- The human papillomavirus (HPV) vaccine Gardasil, developed to prevent cervical cancer, also appears to block pre-cancerous vulval and vaginal lesions, researchers said.